n-acetylneuraminic acid has been researched along with Pulmonary Hypertension in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiles, PG; Gruppo, RA; Kim, NH; Magana, MM; Marsh, JJ; Morris, TA; Noskovack, KJ; Woods, VL | 1 |
| Ferraz de Souza, B; Lopes, AA; Maeda, NY | 1 |
| Borbolla, JR; Collados, MT; López, S; Massó, FA; Montaño, LF; Páez, A; Sandoval, J | 1 |
1 trial(s) available for n-acetylneuraminic acid and Pulmonary Hypertension
| Article | Year |
|---|---|
Characterization of von Willebrand factor in primary pulmonary hypertension.
Topics: Adrenergic beta-Agonists; Adult; Antigens; Biomarkers; Blotting, Western; Calcium Channel Blockers; Electrocardiography; Electrophoresis, Agar Gel; Endothelium, Vascular; Female; Humans; Hydralazine; Hypertension, Pulmonary; Infusions, Intra-Arterial; Isoproterenol; Male; N-Acetylneuraminic Acid; Nifedipine; Prognosis; Pulmonary Artery; Pulmonary Wedge Pressure; Vasodilation; Vasodilator Agents; von Willebrand Factor | 1999 |
2 other study(ies) available for n-acetylneuraminic acid and Pulmonary Hypertension
| Article | Year |
|---|---|
Abnormally sialylated fibrinogen gamma-chains in a patient with chronic thromboembolic pulmonary hypertension.
Topics: Adult; Chronic Disease; Fibrinogens, Abnormal; Humans; Hypertension, Pulmonary; Male; Mass Spectrometry; N-Acetylneuraminic Acid; Thromboembolism | 2007 |
Decreased sialic acid content of plasma von Willebrand factor in precapillary pulmonary hypertension.
Topics: Adolescent; Adult; Child; Female; Glycosylation; Humans; Hypertension, Pulmonary; Male; Middle Aged; N-Acetylneuraminic Acid; Platelet Activation; Protein Processing, Post-Translational; Thiobarbituric Acid Reactive Substances; von Willebrand Factor; Wheat Germ Agglutinins | 2000 |